These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8428687

  • 1. Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
    Higashihara J, Berens ME, Collins LA, Homesley HD, Welander CE.
    Gynecol Oncol; 1993 Feb; 48(2):171-9. PubMed ID: 8428687
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
    Sagawa T, Yamashita K, Kawamura M, Shimizu T, Haga H, Yorozu Y, Kasamo M, Fujita M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
    [Abstract] [Full Text] [Related]

  • 3. Combined antitumour activity of mitomycin C, 5-fluorouracil and interleukin-2 against human colon cancer cells.
    Ishihara M, Kubota T, Watanabe M, Kawano Y, Narai S, Yasui N, Otani Y, Teramoto T, Kitajima M.
    Anticancer Res; 1999 Jul; 19(1A):313-6. PubMed ID: 10226560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Jul; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y.
    Anticancer Res; 2001 Jul; 21(6A):4083-6. PubMed ID: 11911296
    [Abstract] [Full Text] [Related]

  • 14. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S.
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [Abstract] [Full Text] [Related]

  • 15. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T, Kuraishi Y, Aiba K, Inoue K.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R.
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.